Novartis is proposing to acquire the contract manufacturer CellforCure of France in order to boost capacity for the manufacture of cell and gene therapies. Financial terms of the proposed transaction were not disclosed. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
